My husband, John Dobbs, who has died aged 81, brought about transformative shifts in the approach to chronic brain disease. A lateral thinker with a rare breadth and depth of knowledge, his influence on work relating to the drivers and mediators of Parkinson’s disease was gamechanging.
In 2000, he established the Host Microbiome Interaction: Clinical Pharmacology and Therapeutics (HMI:CPT) group at the Institute of Pharmaceutical Science, King’s College London, holding honorary consultantships in gastroenterology at King’s College hospital and the Maudsley hospital. He jointly led, with myself and André Charlett, a statistician and modeller, the “gut-brain axis clinic” research until his last research clinic in December 2025.
